The clinical epidemiology of cardiac disease in chronic renal failure

Journal of the American Society of Nephrology

Volumn 10, Issue 7, 1999, Pages 1606-1615

  Parfrey, Patrick S ^a   Foley, Robert N ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANEMIA; ANGIOCARDIOGRAPHY; CARDIOMYOPATHY; CHRONIC KIDNEY FAILURE; DIABETES MELLITUS; DYSLIPIDEMIA; HEART DISEASE; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART SCINTISCANNING; HEMODIALYSIS; HUMAN; HYPERTENSION; HYPOALBUMINEMIA; ISCHEMIC HEART DISEASE; KIDNEY TRANSPLANTATION; M MODE ECHOCARDIOGRAPHY; MORTALITY; PATHOGENESIS; PERITONEAL DIALYSIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 0033057143     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Levey AS, Beto JA, Coronado BE, Eknoyan G, Foley RN, Kasiske BL, Klag ML, Mailloux LU, Manske CL, Meyer KB, Parfrey PS, Pfeffer MA, Wenger NK, Wilson PWF, Wright JT: Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? Am J Kidney Dis 32: 853-906, 1998
2. U.S. Renal Data System: USRDS 1998 Annual Data Report, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, April 1998
3. National Kidney Foundation Task Force on Cardiovascular Disease: Controlling the epidemic of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32[Suppl 3]: S1-S199, 1998
4. Parfrey PS (editor): Cardiac disease in chronic uremia: Uremia-related risk factors. Semin Dial 12: 1-132, 1999
5. Rostand RG, Kirk KA, Rutsky EA: Dialysis ischemic heart disease: Insights from coronary angiography. Kidney Int 25: 653-659, 1984
6. London G, Parfrey PS: Cardiac disease in chronic uremia: Pathogenesis. Adv Renal Replace Ther 4: 194-211, 1997
7. London GM, Guerin AP, Marchais SJ: Cardiac and arterial interactions in end-stage renal disease. Kidney Int 50: 600-608, 1996
8. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray D, Barre PE: Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int 49: 1428-1434, 1996
9. Murphy SW, Parfrey PS: Screening for cardiovascular disease in dialysis patients. Curr Opin Nephrol Hypertens 5: 532-540, 1996
10. Dahan M, Viron BM, Faraggi M, Himbert DL, Legallicier BJJ, Kolta AM, Pessione EF, Galudec DL, Gourgon R, Mignon FE: Diagnostic accuracy and prognostic value of combined dipyridamole-exercise thallium imaging in hemodialysis patients. Kidney Int 54: 255-262, 1998
11. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE: The outcome and risk factors for left ventricular disorders in chronic uremia. Nephrol Dial Transplant 11: 1277-1285, 1996
12. Harnett JD, Murphy B, Collingwood P, Parfrey PS: The reliability and validity of echocardiographic measurement of left ventricular mass in hemodialysis patients. Nephron 65: 212-214, 1993
13. Harnett JD, Foley RN, Kent GM, Barre PE, Murray DC, Parfrey PS: Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis, and risk factors. Kidney Int 49: 1428-1434, 1996
14. Foley RN, Parfrey PS, Sarnak M: Epidemiology of cardiovascular disease in chronic renal failure. Am J Kidney Dis 32[Suppl 3]: S12-S19, 1998
15. Levin A, Singer J, Thompson CR, Ross H, Lewis M: Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention. Am J Kidney Dis 27: 347-354, 1996
16. Johnstone LM, Jones CL, Grigg LE, Wilkinson JL, Walker RG, Powell HR: Left ventricular abnormalities in children, adolescents and young adults with renal disease. Kidney Int 50: 998-1006, 1996
17. Levin A, Thompson CR, Ethier J, Carlisle EF, Tobe S, Mendelssohn D, Burgess E, Jindal K, Barrett B, Singer J, Djurdjev O: Left ventricular mass increase in early renal disease: Impact of decline in hemoglobin. Am J Kidney Dis 1999, in press
18. U.S. Renal Data System: The USRDS Dialysis Morbidity and Mortality Study, Wave 2. Am J Kidney Dis 30[2 Suppl 1]: S67-S85, 1997
19. Barrett BJ, Parfrey PS, Morgan J, Barre P, Fine A, Goldstein MB, Handa SP, Jindal KK, Kjellstrand CM, Levin A, Mandin H, Muirhead N, Richardson RM: Prediction of early death in end stage renal disease patients receiving dialysis. Am J Kidney Dis 29: 214-222, 1997
20. Valsania P, Sarich SW, Kowalchuk GJ: Severity of coronary artery disease in young patients with insulin-dependent diabetes mellitus. Am Heart J 122: 695-700, 1991
21. Grossman E, Shemesh J, Shamiss A, Thaler M, Carroll J, Rosenthal T: Left ventricular mass in diabetes-hypertension. Arch Intern Med 152: 1001-1004, 1992
22. Van Hoevan KH, Factor SM: A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease circulation. Circulation 82: 848-855, 1990
23. Foley RN, Culleton BF, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: Cardiac disease in diabetic end-stage renal disease. Diabetologia 40: 1307-1312, 1997
24. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 5: 2024-2031, 1995
25. London GM, Fabiani F: Left ventricular dysfunction in end-stage renal disease: Echocardiographic insights. In: Cardiac Dysfunction in Chronic Uremia, edited by Parfrey PS, Harnett JD, Boston, Kluwer, 1992, pp 117-138
26. Young EW, Carroll LE, Wolfe RA: Trends in comorbidity and residual renal function in patients starting treatment for end-stage renal disease [Abstract]. J Am Soc Nephrol 6: 569A, 1995
27. Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE: Long-term evolution of cardiomyopathy in dialysis patients. Kidney Int 54: 1720-1725, 1998
28. Churchill DN, Taylor DW, Cook RJ, LaPlante P, Barre P, Cartier P, Fay W, Goldstein M, Jindal K, Mandin H, McKenzie JK, Muirhead N, Parfrey PS, Posen GA, Slaughter D, Ulan RA, Werb R: Canadian Hemodialysis Morbidity Study. Am J Kidney Dis 19: 214-234, 1992
29. Raine AEG, Margreiter R, Brunner FP, Ehrich JHH, Geerlings W, Landais P, Loirat C, Mallick NP, Selwood NH, Tufveson G, Valderrabano F: Report on management of renal failure in Europe, XXII, 1991. Nephrol Dial Transplant 7[Suppl 2]: 7-35, 1992
30. Herzog CA, Ma JZ, Collins AJ: Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 339: 799-805, 1998
31. Murphy SE, Foley RN, Barrett BJ, Parfrey PS, Kent GM, Morgan J, Barre P, Campbell P, Fine A, Goldstein M, Handa P, Jindal K, Levin A, Mandin H, Muirhead N, Richardson R: Comparative mortality of hemodialysis and peritoneal dialysis in Canada [Abstract]. J Am Soc Nephrol 9: 237A, 1998
32. Foley RN, Parfrey PS, Harnett JD, Kent GM, O'Dea R, Murray DC, Barre PE: Mode of dialysis therapy and mortality in end-stage renal disease. J Am Soc Nephrol 9: 267-276, 1998
33. Huting J, Kramer W, Reittinger J, Kuhn K, Wizemann V, Schutterle G: Cardiac structure and function in continuous ambulatory peritoneal dialysis: Influence of blood purification and hypercirculation. Am Heart J 119: 334-352, 1990
34. Lameire N, Bernaert P, Lambert MC, Vijt D: Cardiovascular risk factors and their management in patients on continuous ambulatory peritoneal dialysis. Kidney Int 46[Suppl 48]: S31-S38, 1994
35. Bloembergen WE, Port FK, Mauger EA: A comparison of cause of death between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 6: 184-191, 1995
36. Harnett JD, Kent GM, Barre PE, Taylor R, Parfrey PS: Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients. J Am Soc Nephrol 4: 1486-1490, 1994
37. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: Impact of hypertension on cardiomyopathy, morbidity and mortality in end stage renal disease. Kidney Int 49: 1379-1385, 1996
38. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: Hypoalbuminemia, cardiac morbidity and mortality in end stage renal disease. J Am Soc Nephrol 7: 728-736, 1996
39. Bergstrom J, Lindholm B: Malnutrition, cardiac disease and mortality: An integrated point of view. Am J Kidney Dis 32: 834-841, 1998
40. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: The impact of anemia on cardiomyopathy, morbidity and mortality in end stage renal disease. Am J Kidney Dis 28: 53-61, 1996
41. Murphy SW, Foley RN, Parfrey PS: Screening and treatment for cardiovascular disease in patients with chronic renal disease. Am J Kidney Dis 32[Suppl 3]: S184-S199, 1998
42. Kasiske BL: Hyperlipidemia in patients with chronic renal disease. Am J Kidney Dis 32[Suppl 3]: S142-S156, 1998
43. Wheeler DC: Abnormalities of lipoprotein metabolism in CAPD patients. Kidney Int 50[Suppl 56]: S41-S46, 1996
44. Cressman MD, Heyka RJ, Paganini EP: Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients. Circulation 86: 475-482, 1992
45. Tschope W, Koch M, Thomas B, Ritz E, and the German Study Group Diabetes and Uremia: Serum lipids predict cardiac death in diabetic patients on maintenance hemodialysis: Results of a prospective study. Nephron 64: 354-358, 1993
46. London GM, Pannier B, Guerin AP: Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease: Comparative effects of ACE inhibition and calcium channel blockade. Circulation 90: 2786-2796, 1994
47. Foley RN, Parfrey PS, Morgan J, Barre P, Campbell P, Cartier P, Handa P, Kingma I, Lau C, Levin A, Mendelssohn D, Muirhead N, Murphy B, Murray D, Plante R: A randomized controlled trial of complete vs partial correction of anemia in hemodialysis patients with asymptomatic concentric LV hypertrophy or LV dilatation [Abstract]. J Am Soc Nephrol 9: 208A, 1998
48. Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, Schwab SJ, Goodkin DA: The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 339: 584-590, 1998
49. Parfrey PS, Harnett JD, Foley RN, Kent GM, Murray DC, Barre PE, Guttmann RD: Impact of renal transplantation on uremic cardiomyopathy. Transplantation 60: 908-914, 1995
50. Lindholm A, Albrechtsen D, Frodin L, Tufveson G, Persson NH, Lundgren G: Ischemic heart disease: Major cause of death and graft loss after renal transplantation in Scandinavia. Transplantation 60: 451-457, 1995
51. Manske CL, Wilson RF, Wang Y, Thomas W: Atherosclerotic vascular complications in diabetic transplant candidates. Am J Kidney Dis 29: 601-607, 1997
52. Kasiske BL, Guijarro C, Massy ZA: Cardiovascular disease after renal transplantation. J Am Soc Nephrol 7: 158-165, 1996
53. West M, Sutherland DE, Matas AJ: Kidney transplant recipients who die with functioning grafts, serum creatinine level and cause of death. Transplantation 62: 1029-1031, 1996